Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well-documented publication which meets basic scientific principles

Data source

Reference
Reference Type:
publication
Title:
The mutagenicity of mono- and di-functional aromatic glycidyl compounds
Author:
Seiler, JP
Year:
1984
Bibliographic source:
Mutation Research, 135 (1984) 159-167

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
ICR mice were treated orally with a single dose of the test substance. After 24, 48, 72 h bone marrow cells were prepared and evaluated for of micronucleated polychromatic erythrocytes.
GLP compliance:
not specified
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
Resorcinol diglycidyl ether
IUPAC Name:
Resorcinol diglycidyl ether
Constituent 2
Reference substance name:
m-bis(2,3-epoxypropoxy)benzene
EC Number:
202-987-5
EC Name:
m-bis(2,3-epoxypropoxy)benzene
Cas Number:
101-90-6
IUPAC Name:
2,2'-[1,3-phenylenebis(oxymethylene)]dioxirane
Details on test material:
- Name of test material (as cited in study report): Resorcinol diglycidyl ether (RDGE)
- Analytical purity: >98%

Test animals

Species:
mouse
Strain:
ICR
Sex:
male/female

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
- Vehicle(s)/solvent(s) used: polyethylene glycol (PEG 400)
Duration of treatment / exposure:
24, 48, 72 h
Frequency of treatment:
single treatment
Doses / concentrations
Remarks:
Doses / Concentrations:
300, 600 mg/kg bw
Basis:
actual ingested

Examinations

Tissues and cell types examined:
bone marrow erythrocytes

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
yes
Remarks:
tested up to acutely toxic levels

Any other information on results incl. tables

 

 

frequency (± SD) of micronucleated erythrocytes per 1000 polychromatic erythrocytes at dose level:

fixation time [h]

300 mg/kg bw

600 mg/kg bw

24

0.0 (1.5)

0.0 (1.9)

48

not tested

0.9 (1.3)

72

not tested

0.4 (0.6)

 

  

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative
In this mouse bone marrow micronucleus assay, Resorcinol diglycidyl ether did not induce an increase in the frequency of micronucleated polychromatic erythrocytes.
Executive summary:

In an ICR mouse bone marrow micronucleus assay, male and female mice were treated orally with Resorcinol diglycidyl ether at doses of 300 and 600 mg/kg bw.  Bone marrow cells were harvested at 24 h (300 and 600 mg/kg bw), 48 and 72 h (600 mg/kg bw only) post-treatment.  The vehicle was polyethylene glycol (PEG 400). Animals were treated up to acutely toxic levels (however, signs of toxicity are not described in the publication).

There was no significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time and dose level.